Stock Worth Watching: It Seems Cesca Therapeutics Inc Will Go Down. Have Another Big Decline

Stock Worth Watching: It Seems Cesca Therapeutics Inc Will Go Down. Have Another Big Decline

The stock of Cesca Therapeutics Inc (NASDAQ:KOOL) is a huge mover today! The stock decreased 7.79% or $0.25 on November 23, hitting $2.96. About 61,841 shares traded hands. Cesca Therapeutics Inc (NASDAQ:KOOL) has declined 3.90% since April 22, 2016 and is downtrending. It has underperformed by 9.31% the S&P500.
The move comes after 7 months negative chart setup for the $31.11M company. It was reported on Nov, 24 by Barchart.com. We have $2.75 PT which if reached, will make NASDAQ:KOOL worth $2.18 million less.

Analysts await Cesca Therapeutics Inc (NASDAQ:KOOL) to report earnings on February, 21.

Cesca Therapeutics Inc (NASDAQ:KOOL) Ratings Coverage

Out of 2 analysts covering Cesca Therapeutics (NASDAQ:KOOL), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. Cesca Therapeutics has been the topic of 4 analyst reports since August 25, 2015 according to StockzIntelligence Inc. The stock has “Buy” rating given by Maxim Group on Tuesday, November 17. The firm has “Buy” rating by H.C. Wainwright given on Monday, September 21. The firm earned “Sell” rating on Tuesday, August 25 by Zacks. Maxim Group downgraded the stock to “Hold” rating in Tuesday, December 22 report.

According to Zacks Investment Research, “Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation, processing and preservation of cell and tissue therapy products. The Company sells its products in approximately 30 countries throughout the world to customers that include private and public cord blood banks, surgeons, hospitals and research institutions. Cesca Therapeutics Inc., formerly known as ThermoGenesis Corp., is headquartered in Rancho Cordova, California.”

More notable recent Cesca Therapeutics Inc (NASDAQ:KOOL) news were published by: Bizjournals.com which released: “Cesca Therapeutics raises $2.5 million in private placement of stock” on August 04, 2016, also Bizjournals.com with their article: “Shares of Rancho Cordova-based Cesca Therapeutics jump 27 percent in a day” published on October 24, 2016, Globenewswire.com published: “Cesca Therapeutics Granted Third U.S. Patent Relating to Its Proprietary …” on October 18, 2016. More interesting news about Cesca Therapeutics Inc (NASDAQ:KOOL) were released by: Marketwatch.com and their article: “/quotes/zigman/3870025/realtime” published on November 09, 2010 as well as Globenewswire.com‘s news article titled: “Cesca Therapeutics to Announce First Quarter Fiscal 2017 Results on November …” with publication date: November 16, 2016.

KOOL Company Profile

Cesca Therapeutics Inc., incorporated on July 3, 1986, is clinical-stage biotechnology company. The Firm develops and markets integrated cellular therapies and delivery systems. The Firm is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. The Firm focuses on the business of research, development and commercialization of autologous cell therapeutics for use in the regenerative medicine industry.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment